5 Undervalued Pharmaceuticals Stocks for Tuesday, August 25
Discover the top 5 undervalued Pharmaceuticals stocks for Tuesday, August 25 based on AAII’s Stock Grades.Tudor Pop
| SECTOR | INDUSTRY |
| Health Care | Pharmaceuticals |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Michael Rose
Michael Rose
Jenna Brashear
Jenna Brashear
| Share Statistics | PBH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,224.2 | $609.5 | 55% |
|
| Shares Out (Mil) | 47.6 | 43.4 | 46% |
|
| Institutional Ownership | 98.8% | 83.9% | 82% |
|
| Float (Mil) | 46.7 | 45.7 | 45% |
|
| Beta | 0.33 | 0.73 | 19% |
|
| Avg Daily Volume (000s) | 450 | 309 | 58% |
|
| Price Change (52-week) |
(27.8%) | 64.9% | 27% |
|
| Growth | PBH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.9% | 6.7% | 27% |
|
| Net Income (5yr) | 2.9% | (1.6%) | 44% |
|
| EPS (5yr) | 3.8% | 15.1% | 37 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 10.8% | (15.0%) | 70% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 8 | 8 | |
| Current EPS | $1.069 | $4.568 | $5.081 | |
| Month Ago EPS | $1.067 | $4.568 | $5.081 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $1.100 | $4.573 | $5.010 | |
| Year/Year Chg | 75.2% | 16.8% | 33.4% | |
| Financials | PBH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,105 | $317 | 51% |
|
| Net Income (TTM) (Mil) | $172 | ($11) | 66% |
|
| EPS (TTM) | $3.587 | ($0.700) | 81% |
|
| Operating Cash Flow (TTM) (Mil) | $249 | ($7) | 62% |
|
| Net Cash Flow (TTM) (Mil) | ($50) | $6 | 19% |
|
| Long-Term Debt (Q1) (Mil) | $2,044 | $6 | 74% |
|
| Enterprise Value (Q1) (Mil) | $4,409 | $525 | 60% |
|
| Valuation | PBH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.16 | 2.61 | 28% |
|
| P/E | 13.1 | 17.0 | 31% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 3.5 | 1.0 | 82% |
|
| Ratios | PBH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 54.8% | 68.8% | 67% |
|
| Net Margin | 15.6% | 0.8% | 73% |
|
| ROA | 4.3% | (22.7%) | 68% |
|
| ROE | 9.1% | (22.8%) | 54% |
|
| Liabilities to Assets | 58.0% | 33.1% | 51% |
|
| F-Score | 4 | 3 | 33% |
|
Prestige Consumer Healthcare Inc. did not pass any screens on 9/11/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors